Clinical Trial Update: Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing enzastaurin versus placebo with pemetrexed in advanced or metastatic non-small cell lung cancer has completed with results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Enzastaurin (enzastaurin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-07-01